Global
Treatment access is the bottleneck
WHO emphasizes opioid agonist maintenance treatment, naloxone, harm reduction, and psychosocial support, while access remains far below need in many countries.
Substance-use care pathway
Addictions Nursing Simulation Training
Build stigma-aware assessment, overdose response, withdrawal recognition, medication treatment literacy, and recovery support into simulation.
Harm-reduction pathway
Psychiatric nursing
Evidence-linked
5,630
Reported Canadian opioid toxicity deaths in 2025
Health Canada reported 5,630 apparent opioid toxicity deaths in 2025; most were accidental and concentrated in BC, Alberta, and Ontario. Last updated June 15, 2026.
Field briefing
What this practice area is doing now
Addictions content needs a different design language than general mental health: faster scanning, stronger contrast, and clear pathways from effect to assessment to treatment. Learners need to see intoxication, withdrawal, trauma, stigma, infectious risk, pain, housing, and mental illness as one clinical picture.
The dominant North American trend is a volatile toxic drug supply, with fentanyl, stimulants, benzodiazepine-like sedatives, xylazine, nitazenes, and regional shifts complicating overdose response. Canada-specific pages should foreground apparent opioid toxicity deaths, stimulant co-involvement, naloxone, OAT access, safer-use education, and respectful documentation.
Treatment coverage should be explicit: buprenorphine/naloxone, methadone, slow-release oral morphine where appropriate, injectable OAT in specialized contexts, contingency management for stimulant use disorder, alcohol-use pharmacotherapy, benzodiazepine tapering, and integrated mental health care.
North America
Polysubstance toxicity is the norm
Fentanyl plus stimulants, sedatives, and emerging synthetics changes assessment. Nurses need to anticipate recurrent sedation, respiratory depression, agitation, wounds, infection, and post-overdose engagement.
Canada
Regional concentration and stimulant co-use
Health Canada data show 2025 apparent opioid toxicity deaths were mostly accidental, mostly male, and heavily concentrated in BC, Alberta, and Ontario, with stimulant involvement common.
Psychiatric nursing skills covered
Simulation-ready competencies
These are the practical behaviours that should show up in scenarios, checklists, reflective feedback, and faculty notes.
- Overdose response: airway, breathing, naloxone, observation, recurrent toxicity, xylazine wound awareness, and compassionate post-event engagement.
- Medication treatment literacy: buprenorphine induction, methadone safety, missed-dose risk, precipitated withdrawal, and continuity after discharge.
- Substance effects teaching for opioids, stimulants, alcohol, cannabis, benzodiazepines, sedatives, and polysubstance presentations.
- Language discipline: person-first charting, stigma reduction, motivational interviewing, harm-reduction plans, and family/community safety.
MindCare scenario practice
What educators and learners can practise
Designed to help faculty translate research signals into scenario prompts, debrief questions, and repeatable clinical judgment practice.
For nursing faculty
Use this pathway to teach fast clinical recognition without losing respect, autonomy, or recovery-oriented communication.
For students
Practise overdose response, withdrawal language, medication safety, and documentation that avoids stigma.
- Unresponsive patient response with airway, breathing, naloxone, observation, and compassionate debrief.
- Withdrawal assessment, missed-dose risk, and medication continuity after discharge.
- Polysubstance presentations involving opioids, stimulants, sedatives, alcohol, and cannabis.
- Motivational interviewing, harm-reduction planning, and person-first documentation.
Key people and institutions
Who to track
Links point to primary institutional, personal, university, guideline, or publication pages where available.
Nora Volkow, NIDA
Addiction neuroscience and national research strategy
A central voice for addiction as a brain, health, and public-policy issue rather than a moral failure. Useful for stigma-sensitive nursing framing.
NIDA HEAL Initiative
United States opioid and overdose research strategy
Tracks research priorities around medications, overdose prevention, polysubstance use, pain, and implementation.
Health Canada / PHAC opioid and stimulant harms surveillance
Canadian public health data
The best anchor for Canadian distinctions and regional trend teaching.
ASAM
Clinical guidelines for addiction medicine
The 2025 benzodiazepine tapering guideline is useful for teaching gradual dose reduction, withdrawal risk, and avoiding abrupt discontinuation.
Treatments, guidance, and notable activity
What changed recently
Activity is included only where it changes nursing education, risk monitoring, patient counselling, or care pathways.
Updated opioid dependence and overdose guidance
WHO updated guidance on opioid dependence treatment and overdose prevention, reinforcing OAT, naloxone, harm reduction, and psychosocial support.
Benzodiazepine tapering guidance
The ASAM-led joint guideline gives a practical framework for taper pace, monitoring, level of care, and patient-centered planning.
Cannabis and psychosis risk as a teaching thread
Canadian cannabis education should include THC potency, edibles duration, youth risk, psychosis signals, and safe counselling without scare tactics.
Related evidence routes
Continue into the vault
Topical links keep this specialty connected to NurseTrainer research collections and Canadian context pages.
Faculty and learner questions
Common questions
What does addictions nursing simulation need to include?
Include overdose response, withdrawal, medication treatment, substance effects, trauma history, infectious risk, and stigma-aware communication.
Why separate Canada from North America here?
Canada-specific teaching should foreground Health Canada toxicity surveillance, regional patterns, OAT access, naloxone, and safer-use education.
How should polysubstance risk be taught?
Teach learners to expect mixed sedation, agitation, respiratory depression, wounds, infection risk, and recurrent toxicity after initial reversal.
Source authority
Evidence trail
Authoritative links used to ground this page. Country distinctions are called out only when they change the teaching point.
Health Canada opioid and stimulant harms
Canadian deaths, hospitalizations, stimulant co-involvement, age, sex, and regional patterns.
NIDA xylazine topic page
Clinical and public health context for xylazine in the drug supply.
SAMHSA National Helpline
Treatment referral and support resource for U.S. readers.
Canada alcohol guidance
Canadian continuum-of-risk framing for alcohol education.
More specialty briefings
Continue exploring
Mental health nursing hub
Mental Health
Teach mood, anxiety, suicide prevention, access gaps, and continuity of care with evidence-linked psychiatric nursing scenarios.
Clinical AI safety moduleAI Psychiatry
Teach app evaluation, privacy, bias, crisis escalation, and clinician-in-the-loop care for digital mental health tools.
Youth mental health pathwayYouth Mental Health
Teach early disclosure, self-harm, eating-disorder acuity, family work, and social media assessment with age-aware scenarios.
Dignity rounds pathwayOlder Adults
Teach dementia, delirium, depression, antipsychotic stewardship, caregiver strain, and long-term care decision-making.